Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00181)
| DIG Name |
Meglumine
|
||||
|---|---|---|---|---|---|
| Synonyms |
meglumine; N-Methyl-D-glucamine; 6284-40-8; N-Methylglucamine; Meglumin; 1-Deoxy-1-(methylamino)-D-glucitol; Meglumina; 1-Deoxy-1-methylaminosorbitol; D-Glucitol, 1-deoxy-1-(methylamino)-; (2R,3R,4R,5S)-6-(Methylamino)hexane-1,2,3,4,5-pentaol; N-Methyl-D(-)-glucamine; N-Methylsorbitylamine; Megluminum; Methylglucamin; Megluminum [INN-Latin]; UNII-6HG8UB2MUY; Meglumina [INN-Spanish]; (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol; Sorbitol, 1-deoxy-1-methylamino-; MFCD00004707; 6HG8UB2MUY; CHEBI:59732; D-1-Deoxy-1-(methylamino)glucitol; NSC 7391; NSC 52907; DSSTox_CID_3244; DSSTox_RID_76939; DSSTox_GSID_23244; C7H17NO5; n-methyl-d-glucamine, 99%; EINECS 228-506-9; N-Methylglucamine solution; NSC-7391; NSC52907; NSC-52907; Meglumine [USP:INN:BAN:JAN]; N-methyl-glucamine; N-Methyl glucamine; NCGC00166125-01; CAS-6284-40-8; N-Methylglucamine solution (70% or less); EC 228-506-9; SCHEMBL2193; ARONIS27014; BIDD:GT0676; Meglumine (JP17/USP/INN); CHEMBL1200570; DTXSID0023244; 1-deoxy-1-(methylamino)-glucitol; 1-Methylamino-1-deoxy-D-glucitol; HMS2089B05; HMS3714B10; Pharmakon1600-01300029; EBD71934; HY-B0342; ZINC2020259; Tox21_112330; Tox21_302037; NSC759607; s1974; AKOS005167162; AKOS015850890; N-methyl-1-amino-1-deoxy-D-glucitol; Tox21_112330_1; AC-4692; CCG-220884; NSC-759607; NCGC00166125-02; NCGC00255365-01; AC-17087; AS-12002; SBI-0206683.P002; AB0011121; Meglumine, meets USP testing specifications; AM20100540; M0227; SW199350-2; D01796; AB00430469-03; AB00430469_05; Glucitol, 1-deoxy-1-(methylamino)-, D- (8CI); Q288875; SR-05000001446; N-Methyl-D-glucamine, 99.0-100.5% (titration); SR-05000001446-1; BRD-K28595280-001-01-1; N-Methyl-D-glucamine, Vetec(TM) reagent grade, 99%; N-Methyl-D-glucamine, ReagentPlus(R), >=99.0% (T); (2R,3R,4R,5S)-6-methylamino-hexane-1,2,3,4,5-pentaol; Meglumine, United States Pharmacopeia (USP) Reference Standard; N-methyl-(2 (S),3 (R),4 (R),5 (R),6-pentahydroxy-hexyl)-amine; Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material; N-Methyl-D-glucamine, European Pharmacopoeia (EP) Reference Standard
|
||||
| DIG Function |
Buffering agent
|
||||
| Formula |
C7H17NO5
|
||||
| Canonical SMILES |
CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
|
||||
| InChI |
1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1
|
||||
| InChIKey |
MBBZMMPHUWSWHV-BDVNFPICSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 195.21 | Topological Polar Surface Area | 113 | |
| XlogP | -2.8 | Complexity | 134 | ||
| Heavy Atom Count | 13 | Rotatable Bond Count | 6 | ||
| Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 6 | ||
Full List of Drug(s) Co-administrated with This DIG